Alembic Pharmaceuticals announces Successful completion of inspection by USFDA at Bioequivalence Facility

Alembic Pharmaceuticals Ltd has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Bioequivalence Facility located at Vadodara without any observations. The inspection was conducted from 17th October, 2022 to 21st October, 2022.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 548.65 as compared to the previous close of Rs. 542.75. The total number of shares traded during the day was 555 in over 61 trades.

The stock hit an intraday high of Rs. 549.80 and intraday low of 545.10. The net turnover during the day was Rs. 303837.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 USFDA Inspection SuccessfulCompletion BioequivalenceFacility Vadodara